Pfizer Unit Recalls Pain Drug Embeda

Law360, New York (March 17, 2011, 2:18 PM EDT) -- Pfizer Inc.'s recently acquired subsidiary King Pharmaceuticals Inc. is recalling 100,000 bottles of pain medication Embeda from U.S. wholesalers and retailers, marking the fourth time in the last year that the drug has been recalled.

The recall, announced Friday, comes just several weeks after Pfizer completed its $3.6 billion acquisition of King. The drug is being recalled because routine testing discovered that one of its main compounds was degenerating faster than it should, said Pfizer spokesman Rick Chambers.

The recall is unlikely to pose a safety...
To view the full article, register now.